Aprepitant - PDFSEARCH.IO - Document Search Engine

Aprepitant
Results: 58

#	Item
41	CMS Manual System Department of Health & Human Services (DHHS) Pub[removed]Medicare National Coverage Add to Reading List Source URL: www.cms.gov Language: English - Date: 2014-04-15 16:12:23 Alkylating antineoplastic agents Oncology Organofluorides Antiemetics Cancer treatments Chemotherapy-induced nausea and vomiting Aprepitant Chemotherapy Cisplatin Chemistry Medicine Organic chemistry
42	DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services NEW product from the Medicare Learning Network® (MLN) • Add to Reading List Source URL: www.cms.gov Language: English - Date: 2014-04-16 12:11:42 Organofluorides Antiemetics Pharmaceuticals policy Aprepitant Morpholines Chemotherapy-induced nausea and vomiting Medicare Chemotherapy Dacarbazine Medicine Chemistry Oncology
43	CMS Manual System Department of Health & Human Services (DHHS) Pub[removed]Medicare Benefit Policy Add to Reading List Source URL: www.cms.gov Language: English - Date: 2014-04-15 16:12:05 Organofluorides Cancer treatments Antiemetics Lactams Aprepitant Chemotherapy-induced nausea and vomiting Chemotherapy Medicare Cisplatin Medicine Chemistry Oncology
44	BC PharmaCare Newsletter[removed] Add to Reading List Source URL: www.health.gov.bc.ca Language: English - Date: 2014-03-05 12:00:04 Organochlorides Antiemetics Organofluorides Oncology Aprepitant Morpholines Clopidogrel Amlodipine Chemotherapy Chemistry Organic chemistry Medicine
45	The Merck Access Program Enrollment Form Phone: [removed], Fax: [removed]The Merck Access Program PO Box[removed]Phoenix, AZ 85038 Add to Reading List Source URL: www.merckhelps.com Language: English - Date: 2014-05-29 09:32:53 Readington New Jersey Schering-Plough Pharmacology Medicine Health Patient safety Health Insurance Portability and Accountability Act Aprepitant Medical prescription Chemistry Dow Jones Industrial Average Merck & Co.
46	B.C. Ministry of Health Services Drug Coverage Decisions About PharmaCare PharmaCare Coverage Inside Add to Reading List Source URL: www.health.gov.bc.ca Language: English - Date: 2014-03-05 12:02:53 Organofluorides Oncology Aprepitant Lactams Morpholines Chemotherapy-induced nausea and vomiting 5-HT3 antagonist Chemotherapy Ondansetron Medicine Antiemetics Chemistry
47	[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EMEND safely and effectively. See full prescribing information for EMEND. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-03-26 12:39:11 Antiemetics Ketones Organofluorides Oncology Triazoles Aprepitant Chemotherapy-induced nausea and vomiting Ondansetron Dolasetron Chemistry Medicine Organic chemistry
48	Case 3:14-cv[removed]PGS-LHG Document 1 Filed[removed]Page 1 of 31 PageID: 1 Charles M. Lizza William C. Baton SAUL EWING LLP One Riverfront Plaza, Suite 1520 Add to Reading List Source URL: patentdocs.typepad.com Language: English - Date: 2014-06-25 05:00:42 Chemistry Triazoles Civil law Organic chemistry United States patent law Fosaprepitant Merck & Co. Aprepitant Prior art Patent law Antiemetics Organofluorides
49	Proposed Patient Product Information Amendment 08Nov2010 150mg IV Add to Reading List Source URL: www.merck.com Language: English - Date: 2012-07-11 10:15:26 Organofluorides Triazoles Organic chemistry Aprepitant Lactams Morpholines Merck & Co. Fosaprepitant Injection Chemistry Pharmacology Antiemetics
50	concentrations of these drugs, potentially causing serious or lifethreatening reactions[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EMEND safely and effec Add to Reading List Source URL: www.merck.com Language: English - Date: 2014-08-19 07:46:44 Antiemetics Organofluorides Ketones Triazoles Lactams Aprepitant Chemotherapy-induced nausea and vomiting Dolasetron Fosaprepitant Chemistry Organic chemistry Medicine

UPDATE